The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Guar gum as a new antimicrobial peptide delivery system against diabetic foot ulcers Staphylococcus aureus isolates
Abstract
Diabetic patients frequently develop diabetic foot ulcers (DFUs), particularly those patients vulnerable to Staphylococcus aureus opportunistic infections. It is urgent to find new treatments for bacterial infections. The antimicrobial peptide (AMP) nisin is a potential candidate, mainly due to its broad spectrum of action against pathogens. Considering that AMP can be degraded or inactivated before reaching its target at therapeutic concentrations, it is mandatory to establish effective AMP delivery systems, with the natural polysaccharide guar gum being one of the most promising. We analysed the antimicrobial potential of nisin against 23 S. aureus DFU biofilm-producing isolates. Minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), minimum biofilm inhibitory concentration (MBIC) and minimum biofilm eradication concentration (MBEC) were determined for nisin diluted in HCl and incorporated in guar gum gel. Statistical analysis was performed using the Wilcoxon matched-pair test. Nisin was effective against all isolates, including some multidrug-resistant clinical isolates, independent of whether it is incorporated in guar gum. While differences among MIC, MBC and MBIC values were observed for HCl- and guar gum- nisin, no significant differences were found between MBEC values. Inhibitory activity of both systems seems to differ only twofold, which does not compromise guar gum gel efficiency as a delivery system. Our results highlight the potential of nisin as a substitute for or complementary therapy to current antibiotics used for treating DFU infections, which is extremely relevant considering the increase in multidrug-resistant bacteria dissemination. The guar gum gel represents an alternative, practical and safe delivery system for AMPs, allowing the development of novel topical therapies as treatments for bacterial skin infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In that study, S. aureus Z.25.2 was considered susceptible to Nisin A at MIC = 100 µg/mL, a higher value than the one obtained in the present study (MIC of Nisin Z = 6.1 ± 2.2 µg/mL).”
In the citing paper
“offering a safe and effective system for drug delivery by different administrative routes [30,31,32].”
In the citing paper
“In a previous study, the mean MBC value of Nisin A against S. aureus Z.25.2 was 600 µg/mL [31], a much higher value than the one obtained in the present study (MBC of Nisin Z = 18.8 ± 6.9 µg/mL).”
In the citing paper
“Antibiofilm and eradication efficacy of Nisin Z was demonstrated to be superior to that of Nisin A, since results from a previous study showed that Nisin A MBIC value against S. aureus Z.25.2 was 40 µg mL and MBEC values > 1000 µg mL [31].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Bacteriocins: safe, natural antimicrobials for food preservation.
Cleveland, J., Montville, T. J., Nes, I. F., & Chikindas, M. L. (2001) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(01)00560-8 · Cited by 1,835
Stanaway, S., Johnson, D., Moulik, P., & Gill, G. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.05.021 · Cited by 56
Research works printed but not linked: 42
- 10.1155/2011/175145 · DOI
- 10.1007/s13410-016-0492-7 · doi:10.1007/s13410-016-0492-7
- 10.4155/fmc-2015-0002 · DOI
- 10.1177/193229681100500636 · DOI · Paper page
- 10.1016/j.bbamem.2015.10.013 · DOI · Paper page
- Ceri, 1999, The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms, J Clin Microbiol, 37, 1771, 10.1128/JCM.37.6.1771-1776.1999 · DOI · Paper page
- 2013, Performance Standards for Antimicrobial Susceptibility Testing
- 10.1046/j.1464-5491.2003.00860.x · DOI · Paper page
- 10.1039/b804469b · DOI · Paper page
- 2015, Annual Report of the European Antimicrobial Resistance Surveillance Network
- 2006, The use of nisin (E 234) as a food additive, EFSA Journal, 314, 1
- 10.1093/jac/dkl393 · DOI · Paper page
- 10.1080/10408398.2013.763765 · DOI · Paper page
- 10.1038/nbt1267 · DOI · Paper page
- 10.1016/S0140-6736(03)13169-8 · DOI · Paper page
- 10.1128/mBio.02272-14 · DOI · Paper page
- 10.1016/j.jinf.2006.08.013 · DOI
- 10.5301/ijao.5000027 · DOI · Paper page
- Kirikae, 1998, Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia, Infect Immun, 66, 1861, 10.1128/IAI.66.5.1861-1868.1998 · DOI
- 10.1038/nrd3975 · DOI · Paper page
- 10.1086/424846 · DOI · Paper page
- 10.1111/j.1574-6976.2001.tb00579.x · doi:10.1111/j.1574-6976.2001.tb00579.x · Paper page
- 10.1016/j.diabres.2011.10.001 · DOI · Paper page
- 10.1099/jmm.0.071753-0 · DOI
- 10.2174/1381612821666150310102702 · DOI
- 10.1007/s12223-015-0401-3 · DOI · Paper page
- 10.1186/s12929-016-0250-7 · DOI · Paper page
- 10.1007/s00284-012-0268-3 · DOI
- 10.1128/AAC.00888-13 · DOI · Paper page
- 10.1128/IAI.00318-08 · DOI · Paper page
- 10.1128/AAC.49.7.2612-2617.2005 · DOI · Paper page
- Reddy, 2011, Natural polysaccharides: versatile excipients for controlled drug delivery systems, Asian J Pharm Sci, 6, 275
- 10.1016/j.diabet.2008.02.005 · DOI
- 10.4239/wjd.v2.i2.24 · DOI
- Roglic, 2016, WHO global report on diabetes: a summary, Int J Non-Commun Dis, 1, 3, 10.4103/2468-8827.184853 · DOI · Paper page
- 10.1074/jbc.M504327200 · DOI · Paper page
- 10.1016/S0140-6736(01)05321-1 · DOI · Paper page
- 10.2174/1381612820666140905124312 · DOI
- 10.1016/j.ijbiomac.2016.04.001 · DOI · Paper page
- Vuorisalo, 2009, Treatment of diabetic foot ulcers, J Cardiovasc Surg, 50, 275
- 10.1038/nprot.2007.521 · DOI · Paper page
- 10.1038/415389a · DOI · Paper page
Cited by
Nanocarrier system: An emerging strategy for bioactive peptide delivery
Zhang, X., Li, X., Zhao, Y., Zheng, Q., Wu, Q., & Yu, Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1050647 · Cited by 63
Serrano, I., Alhinho, B., Cunha, E., Tavares, L., Trindade, A., & Oliveira, M. (2023) · Life · doi:10.3390/life13020504 · Cited by 33
Self-citation
Metadata
- Authors
- Santos, R., Gomes, D., Macedo, H., Barros, D., Tibério, C., Veiga, A. S., Tavares, L., Castanho, M., & Oliveira, M.
- Affiliations
- Centro de Investigação Interdisciplinar em Sanidade Animal, Faculdade de Medicina Veterinária, Universidade de Lisboa, Lisbon, Portugal
- ISPA Instituto Universitário SA, Lisbon, Portugal
- Centro de Estudos do Ambiente e do Mar, Faculdade de Ciências, Universidade de Lisboa, Lisbon, Portugal
- Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
- Venue
- Journal of Medical Microbiology
- Publisher
- Microbiology Society
- Published
- 2016-10-18
- Volume
- 65
- Issue
- 10
- Pages
- 1092-1099
- ISSN
- 0022-2615
- 1473-5644
- Cited by
- 37
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.